APA (7th ed.) Citation

Devarapu, S. K., Kumar VR, S., Rupanagudi, K. V., Kulkarni, O. P., Eulberg, D., Klussmann, S., & Anders, H. (2017). Reprint of “Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis”. Clinical Immunology, 185, 119. https://doi.org/10.1016/j.clim.2017.10.011

Chicago Style (17th ed.) Citation

Devarapu, Satish Kumar, Santhosh Kumar VR, Khader Valli Rupanagudi, Onkar P. Kulkarni, Dirk Eulberg, Sven Klussmann, and Hans-Joachim Anders. "Reprint of “Dual Blockade of the Pro-inflammatory Chemokine CCL2 and the Homeostatic Chemokine CXCL12 Is as Effective as High Dose Cyclophosphamide in Murine Proliferative Lupus Nephritis”." Clinical Immunology 185 (2017): 119. https://doi.org/10.1016/j.clim.2017.10.011.

MLA (9th ed.) Citation

Devarapu, Satish Kumar, et al. "Reprint of “Dual Blockade of the Pro-inflammatory Chemokine CCL2 and the Homeostatic Chemokine CXCL12 Is as Effective as High Dose Cyclophosphamide in Murine Proliferative Lupus Nephritis”." Clinical Immunology, vol. 185, 2017, p. 119, https://doi.org/10.1016/j.clim.2017.10.011.